BioSpace News Archive

Drug Development

SCYNEXIS Announces Positive Interim Data from Phase 3 FURI and CARES Studies Highlighting Oral Ibrexafungerp’s Potency Against Severe Fungal Infections

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced positive interim data from its ongoing Phase 3 FURI and CARES studies.

April 22, 2022
·
7 min read
Business

Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer

Stella Diagnostics, Inc. today announced leadership changes in conjunction with the next phase of its business plan.

April 22, 2022
·
6 min read
Biotech Bay

Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors to Outline New Strategic Plan

Nektar Therapeutics (NASDAQ:NKTR) will host an analyst and investor conference call with Nektar executives on Monday, April 25, 2022, at 2:00 p.m. Pacific Standard Time (PST), to outline a new strategic plan for the company and provide updates for the company’s research and development pipeline.

April 22, 2022
·
1 min read
Business

Assertio Holdings, Inc. to Report First Quarter 2022 Financial Results After the Close of Markets on Monday, May 9, 2022

Assertio Holdings, Inc. today announced that it will release first quarter 2022 financial results on Monday, May 9, 2022, after the close of markets.

April 22, 2022
·
2 min read
Pharm Country

IO Biotech Hosting Key Opinion Leader Webinar Series

IO Biotech announced today that it will be hosting a series of key opinion leader (KOL) webinars.

April 22, 2022
·
6 min read
Masker MedTech AB’s inhalational drug works in preclinical models of COVID-19

Using its spike protein, the COVID-19 virus binds to a human protein called ACE2 – like a key being inserted into a lock – and subsequently enters and infects the cell.

April 22, 2022
·
2 min read
BCG Vaccine Market Size 2021-2028 - Increasing Research Activities To Explore Linkage Between BCG Vaccination And COVID-19 Mortality Is A Key Growth Driving Factor

Increasing efforts to accelerate immunization and implementation of TB control strategies in developing countries, rapidly rising prevalence of tuberculosis globally, and increasing use of BCG vaccine to treat superficial carcinoma of bladder are some key factors expected to drive market growth.

April 22, 2022
·
9 min read
Bioinformatics Market Size 2021-2028 - Increasing Importance Of Bioinformatics In Personalized Medicine Is A Key Growth-Driving Factor

Advancements in genomics and proteomics research, rising investment to accelerate drug discovery and development, and development of next-generation sequencing techniques are some key factors expected to drive market growth.

April 22, 2022
·
8 min read
Breast Localization Wire Market Analysis 2022-2030 - Increasing Adoption Of Biopsy Procedures For Diagnosing Breast Abnormalities And Cancerous Tumors

The industry analysis report is considered a valuable source of information about the global Breast Localization Wire industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years

April 22, 2022
·
6 min read
Genotyping Assay Market Size 2021-2028 - Deteriorating DNA Sequencing Costs And Advancements In Genotyping Techniques

Rising investments by public and private organizations in R&D and decreasing costs of DNA sequences are some major factors driving market revenue growth.

April 22, 2022
·
7 min read